Detection and quantification of differentially culturable tubercle bacteria in sputum from patients with tuberculosis

American Journal of Respiratory and Critical Care Medicine

Volumn 194, Issue 12, 2016, Pages 1532-1540

  Chengalroyen, Melissa D ^a   Beukes, Germar M ^a   Gordhan, Bhavna G ^a   Streicher, Elizabeth M ^b   Churchyard, Gavin ^c   Hafner, Richard ^d   Warren, Robin ^b   Otwombe, Kennedy ^e   Martinson, Neil ^a,e,f   Kana, Bavesh D ^a  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b UNIVERSITY OF STELLENBOSCH   (South Africa)

^c AURUM INSTITUTE   (South Africa)

^d NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^e UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^f JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Culturability; HIV; Limiting dilution assay; Resuscitation promoting factors; Tuberculosis

Indexed keywords

ADULT; ARTICLE; BACTERIAL GROWTH; BACTERIAL LOAD; BACTERIAL STRAIN; BACTERIUM; BACTERIUM CULTURE; BACTERIUM DETECTION; CD4 LYMPHOCYTE COUNT; COLONY FORMING UNIT; CONTROLLED STUDY; CULTURE FILTRATE SUPPLEMENTATION; CULTURE MEDIUM; DIFFERENTIALLY CULTURABLE TUBERCLE BACTERIA; EX VIVO STUDY; FEMALE; GROWTH STIMULATION; HEAT TREATMENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; LIMIT OF QUANTITATION; LUNG TUBERCULOSIS; MALE; MICROBIOLOGICAL PARAMETERS; MIDDLE AGED; MOST PROBABLE NUMBER; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; RESUSCITATION PROMOTING FACTOR; SPUTUM; SPUTUM ANALYSIS; SPUTUM CULTURE; SPUTUM SMEAR; COMORBIDITY; HIV INFECTIONS; IMMUNOLOGY; ISOLATION AND PURIFICATION; PREVALENCE; SENSITIVITY AND SPECIFICITY; SOUTH AFRICA; TUBERCULOSIS, PULMONARY;

ADULT; COMORBIDITY; FEMALE; HIV INFECTIONS; HUMANS; MALE; MYCOBACTERIUM TUBERCULOSIS; PREVALENCE; SENSITIVITY AND SPECIFICITY; SOUTH AFRICA; SPUTUM; TUBERCULOSIS, PULMONARY;

EID: 85007453750     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201604-0769OC     Document Type: Article

References (23)

1. Dheda K, Barry CE, 3rd, Maartens G. Tuberculosis. Lancet 2015;387:1211-1226.
2. Zumla A, Kim P, Maeurer M, Schito M. Zero deaths from tuberculosis: progress, reality, and hope. Lancet Infect Dis 2013;13:285-287.
3. Zumla A, Nahid P, Cole ST. Advances in the development of new tuberculosis drugs and treatment regimens. Nat Rev Drug Discov 2013;12:388-404.
4. Wallis RS, Kim P, Cole S, Hanna D, Andrade BB, Maeurer M, Schito M, Zumla A. Tuberculosis biomarkers discovery: developments, needs, and challenges. Lancet Infect Dis 2013;13:362-372.
5. Young M, Mukamolova GV, Kaprelyants AS. Mycobacterial dormancy and its relation to persistence. In: Parish T, editor. Mycobacterium: molecular biology. Norwich, UK: Horizon Scientific; 2005. pp. 265-320.
6. Chao MC, Rubin EJ. Letting sleeping dos lie: does dormancy play a role in tuberculosis? Annu Rev Microbiol 2010;64:293-311.
7. Esmail H, Barry CE III, Young DB, Wilkinson RJ. The ongoing challenge of latent tuberculosis. Philos Trans R Soc Lond B Biol Sci 2014;369:20130437.
8. Kana BD, Mizrahi V. Resuscitation-promoting factors as lytic enzymes for bacterial growth and signaling. FEMS Immunol Med Microbiol 2010;58:39-50.
9. Kana BD, Mizrahi V. Resuscitation promoting factors in bacterial population dynamics during TB infection. Drug Discov Today Dis Mech 2010;7:e13-e18.
10. Nikitushkin VD, Demina GR, Shleeva MO, Guryanova SV, Ruggiero A, Berisio R, Kaprelyants AS. A product of RpfB and RipA joint enzymatic action promotes the resuscitation of dormant mycobacteria. FEBS J 2015;282:2500-2511.
11. Kana BD, Gordhan BG, Downing KJ, Sung N, Vostroktunova G, Machowski EE, Tsenova L, Young M, Kaprelyants A, Kaplan G, et al. The resuscitation-promoting factors of Mycobacterium tuberculosis are required for virulence and resuscitation from dormancy but are collectively dispensable for growth in vitro. Mol Microbiol 2008;67:672-684.
12. Mukamolova GV, Turapov O, Malkin J, Woltmann G, Barer MR. Resuscitation-promoting factors reveal an occult population of tubercle bacilli in sputum. Am J Respir Crit Care Med 2010;181:174-180.
13. Turapov O, O'Connor BD, Sarybaeva AA, Williams C, Patel H, Kadyrov AS, Sarybaev AS, Woltmann G, Barer MR, Mukamolova GV. Phenotypically adapted Mycobacterium tuberculosis populations from sputum are tolerant to first line drugs. Antimicrob Agents Chemother 2016;60:2476-2483.
14. Kolwijck E, Friedrich SO, Karinja MN, van Ingen J, Warren RM, Diacon AH. Early stationary phase culture supernatant accelerates growth of sputum cultures collected after initiation of anti-tuberculosis treatment. Clin Microbiol Infect 2014;20:O418-O420.
15. Dhillon J, Fourie PB, Mitchison DA. Persister populations of Mycobacterium tuberculosis in sputum that grow in liquid but not on solid culture media. J Antimicrob Chemother 2014;69:437-440.
16. Hu Y, Liu A, Ortega-Muro F, Alameda-Martin L, Mitchison D, Coates A. High-dose rifampicin kills persisters, shortens treatment duration, and reduces relapse rate in vitro and in vivo. Front Microbiol 2015;6:641.
17. Turapov O, Glenn S, Kana B, Makarov V, Andrew PW, Mukamolova GV. The in vivo environment accelerates generation of resuscitationpromoting factor-dependent mycobacteria. Am J Respir Crit Care Med 2014;190:1455-1457.
18. Barer MR, Harwood CR. Bacterial viability and culturability. Adv Microb Physiol 1999;41:93-137.
19. Hett EC, Chao MC, Deng LL, Rubin EJ. A mycobacterial enzyme essential for cell division synergizes with resuscitation-promoting factor. PLoS Pathog 2008;4:e1000001.
20. Hett EC, Chao MC, Steyn AJ, Fortune SM, Deng LL, Rubin EJ. A partner for the resuscitation-promoting factors of Mycobacterium tuberculosis. Mol Microbiol 2007;66:658-668.
21. Shleeva M, Goncharenko A, Kudykina Y, Young D, Young M, Kaprelyants A. Cyclic AMP-dependent resuscitation of dormant Mycobacteria by exogenous free fatty acids. PLoS One 2013;8:e82914.
22. Zhang Y, Yang Y, Woods A, Cotter RJ, Sun Z. Resuscitation of dormant Mycobacterium tuberculosis by phospholipids or specific peptides. Biochem Biophys Res Commun 2001;284:542-547.
23. Nazarova EV, Shleeva MO, Morozova NS, Kudykina YK, Vostroknutova GN, Ruzhitsky AO, Selishcheva AA, Sorokoumova GM, Shvets VI, Kaprelyants AS. Role of lipid components in formation and reactivation of Mycobacterium smegmatis "nonculturable" cells. Biochemistry (Mosc) 2011;76:636-644.